Factory Supply Pharmaceutical Intermediate Lafutidine Powder CAS 118288-08-7

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: ST-Lafutidine
• Certification: ISO 9001, FDA
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Use: Healthy
• MOQ: 1kg
• Molecular Formula: C22h29n3o4s
• CAS: 118288-08-7
• Shelf Life: 2 Years
• Assay: 99%
• CAS Nb: 118288-08-7
• Delivery Method: FedEx/DHL/Special Line
• Package: Foil Bag
• Service: Good Service
• Shipping Area: Worldwide/All Countries
• Test Method: HPLC
• Storage: Keep in Cool and Dry Place
• Appearance: White Powder
• Cer: GMP, Hse, ISO 9001, USP, Bp
• Transport Package: 1kg/Bag, 25kg/Drum
• Specification: 99%
• Trademark: SENTIAN
• Origin: China
• Production Capacity: 50000 Kg Per Month

Product Description

.

 

Description

product name	Lafutidine
CAS NO.	118288-08-7
Specification	99%
Appearance	White powder
packing	1kg/bag,25kgs/drum
MOQ	1KG

Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action. It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses gastric acid secretion, but also has cytoprotective properties by the virtue of its property to induce the collagen synthesis in the gastric mucosa. It has a novel mechanism of action in addition to blocking the H2 receptors, it decreases inflammation by modulating calcitonin gene-related peptide (CGRP) and vanilloid receptors It is also found to stimulate mucin biosynthesis and promote the restitution of damaged mucosa.

COA

 

Item	Specification	Test result
Appearance	white powder	Conforms
Assay	99%	Conforms
Heavy metal	≤10ppm	Conforms
Lead	≤2.0ppm	Conforms
As	≤2.0ppm	Conforms
Ca	≤1.0ppm	Conforms
Me	≤0.1ppm	Conforms
Total aerobic microbial count	≤1000CFU/g	Conforms
Total moulds&yeast count	≤100CFU/g	Conforms
Enterobacterial	≤10MPN/g	Conforms
Salmonella	N.D/25g	Conforms
Escherichia coli	N.D/10g	Conforms
Staphylococcus aureus	N.D/10g	Conforms
Pseudomonas aeruginosa	N.D/10g	Conforms
Conclusion: Conform with specification.

 

Application & Funtion

Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action. It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses gastric acid secretion, but also has cytoprotective properties by the virtue of its property to induce the collagen synthesis in the gastric mucosa. It has a novel mechanism of action in addition to blocking the H2 receptors, it decreases inflammation by modulating calcitonin gene-related peptide (CGRP) and vanilloid receptors It is also found to stimulate mucin biosynthesis and promote the restitution of damaged mucosa.
 

 

Company